I agree that this site is using cookies. You can find further informations here.
X
Lee, Keun Seok
658  results:
OpenAccess-fulltext X
Search for persons X
?
1

Clinicopathological Factors Associated with Oncotype DX Ris..:

Song, Ran ; Lee, Dong-Eun ; Lee, Eun-Gyeong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527468/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

A Phase II Trial of S-1 and Oxaliplatin in Patients with Me..:

Lee, Dae-Won ; Keam, Bhumsuk ; Lee, Keun Seok...
Cancer Research and Treatment, Vol.55 No.2, pp.523-530.  , 2023
Link: https://hdl.handle.net/1..
 
?
3

Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced..:

Moon, Yong Wha ; Kim, Seung Ki ; Lee, Keun Seok...
Cancer Research and Treatment, Vol.55 No.3, pp.766-777.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug ..:

Meric-Bernstam, Funda ; Calvo, Emiliano ; Lee, Keun Seok...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543980/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:

Bardia, Aditya ; Jhaveri, Komal ; Kalinsky, Kevin...
Future Oncology.  , 2023
Link: https://hdl.handle.net/1..
 
?
6

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up ..:

Koo, Dong-Hoe ; Lee, Keun Seok ; Sim, Sung Hoon...
info:eu-repo/semantics/altIdentifier/doi/10.2147/BCTT.S406685.  , 2023
Link: https://www.dovepress.co..
 
?
7

Progranulin and Breast Cancer Mortality: 13-Year Follow-Up ..:

Koo, Dong-Hoe ; Lee, Keun Seok ; Sim, Sung Hoon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112348/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advan..:

Modi, Shanu ; Jacot, William ; Yamashita, Toshinari...
New England Journal of Medicine, Vol.387 No.1, pp.9-20.  , 2022
Link: https://hdl.handle.net/1..
 
?
9

Updated Overall Survival of Ribociclib plus Endocrine Thera..:

Lu, Yen-Shen ; Im, Seock-Ah ; Colleoni, Marco...
Clinical Cancer Research, Vol.28 No.5, pp.851-859.  , 2022
Link: https://hdl.handle.net/1..
 
?
10

Long-Term Safety and Effectiveness of PF-05280014 (a Trastu..:

Li, Rubi K ; Tokunaga, Eriko ; Adamchuk, Hryhoriy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847243/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezo..:

Ahn, Hee Kyung ; Sim, Sung Hoon ; Suh, Koung Jin...
JAMA oncology, Vol.8 No.9, pp.1271-1277.  , 2022
Link: https://hdl.handle.net/1..
 
?
12

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advan..:

Modi, Shaun ; Jacot, William ; Yamashita, Toshinari...
Reproducció del document publicat a: https://doi.org/10.1056/nejmoa2203690.  , 2022
Link: http://hdl.handle.net/24..
 
?
13

Updated Overall Survival of Ribociclib plus Endocrine Thera..:

Lu, Yen-Shen ; Im, Seock-Ah ; Colleoni, Marco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377723/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

SIX1, a glycolysis related gene, regulates tumor progressio..:

Kim, Ju-Ha ; Song, Woo-Ju ; Park, Yeonju...
doi:10.5281/zenodo.6550921.  , 2022
Link: https://zenodo.org/recor..
 
?
15

Clinical effectiveness of olaparib monotherapy in germline ..:

Gelmon, Karen A ; Fasching, Peter A ; Couch, Fergus J...
European Journal of Cancer, Vol.152, pp.68-77.  , 2022
Link: https://hdl.handle.net/1..
 
1-15